CAS 54328-33-5

dermatan sulfate sodiumsalt from bovine mucosa

Description:

Dermatan sulfate sodium salt from bovine mucosa, with the CAS number 54328-33-5, is a glycosaminoglycan that plays a crucial role in various biological processes. It is a sulfated polysaccharide composed of repeating disaccharide units, typically consisting of N-acetylgalactosamine and uronic acid. This compound is known for its ability to bind to proteins, influencing cell signaling, tissue repair, and inflammation. Dermatan sulfate exhibits anticoagulant properties, making it relevant in medical applications, particularly in the treatment of cardiovascular diseases. Its sodium salt form enhances its solubility in aqueous solutions, facilitating its use in pharmaceutical formulations. Additionally, dermatan sulfate is derived from bovine mucosa, which raises considerations regarding sourcing and potential immunogenicity. The substance is generally characterized by its high molecular weight and specific sulfation patterns, which contribute to its biological activity. Overall, dermatan sulfate sodium salt is significant in both research and therapeutic contexts, particularly in regenerative medicine and as a biomaterial.

Synonyms:

• Chondroitin sulfate from bovine
• Dermatan Sulfate, Porcine Intestinal Mucosa
• Chondroitinsulfatesodiumsalt

Dermatan Sulfate Sodium Salt

CAS: 54328-33-5

Color and Shape: White to Almost white powder to crystal

Ref: 3B-D3672

Dermatan Sulfate

CAS: 54328-33-5

Natural polymers & modified natural polymers, in primary forms, nesoi

Color and Shape: White Powder

Molecular weight: Average 46275

Ref: 45-1171455

Dermatan (sulphate sodium)

CAS: 54328-33-5

Formula: C₁₇H₃₀NNaO₁₅S

Purity: 90%

Color and Shape: Solid

Molecular weight: 543.4726

Ref: IN-DA003OVO

Dermatan sulphate sodium

CAS: 54328-33-5

Dermatan sulphate sodium

Purity: ≥95%

Ref: 54-BUP20109

Dermatan Sulfate (>90%)

Controlled Product

CAS: 54328-33-5

Applications Dermatan Sulfate is a glycosaminoglycan molecule used in the synthesis of tissue engineering. Used in the synthesis of artificial cartilage as an applicable biomaterial.
References Chen, Y. et al.: Biomat., 28, 2294 (2007); Hirano, S. et al.: J. Biomed. Mat. Res., 56, 556 (2001);

Formula: C₂₀H₂₈O₃

Purity: >90%

Color and Shape: White To Off-White

Ref: TR-D289325

Dermatan Sulfate

CAS: 54328-33-5

Ref: TR-TRC-D289325

Dermatan sulphate sodium

CAS: 54328-33-5

Dermatan sulphate sodium (Chondroitin sulfate B sodium salt) is a linear sulfated polysaccharide, a glycosaminoglycan component of several important proteoglycans, and an activating ligand for the kinase of mesenchymal lymphoma. Dermatan sulphate sodium is an anticoagulant, inhibiting thrombus Dermatan sulphate sodium is an anticoagulant that inhibits thrombosis.

Formula: C₁₄H₂₃NO₁₅S

Color and Shape: Solid

Molecular weight: 477.39

Ref: TM-T84738

Dermatan sulphate sodium

CAS: 54328-33-5

Dermatan sulphate is a glycosaminoglycan found in skin, blood vessels, heart valves, tendons, aorta, spleen and brain and is usually isolated from pig skin or beef lung tissue. The disaccharide repeat unit is composed of L-iduronic acid and N-acetyl-galactosamine-4-sulphate linked β-(1,3) and β-(1,4). There are also small amounts of D-glucuronic acid.

Color and Shape: Powder

Molecular weight: 1,526.03 g/mol

Ref: 3D-YD30120

Dermatan sulphate sodium salt,average MW 92000

CAS: 54328-33-5

Dermatan sulphate is a glycosaminoglycan found in skin, blood vessels, heart valves, tendons, aorta, spleen and brain and is usually isolated from pig skin or beef lung tissue. The disaccharide repeat unit is composed of L-iduronic acid and N-acetyl-galactosamine-4-sulphate linked β-(1,3) and β-(1,4). There are also small amounts of D-glucuronic acid.

Color and Shape: Powder

Ref: 3D-OD153505

Danaparoid sodium - mixture of dermatan sulfate, heparan sulfate and chondroitin sulfate

CAS: 54328-33-5

Danaparoid sodium (the active pharmaceutical ingredient in Orgaran; Merck Sharp and Dohme) is a biopolymeric non-heparin drug that is used as anticoagulant and antithrombotic agent, approved for the prophylaxis of postoperative deep-vein thrombosis.  It consists of a mixture of three glycosaminoglycans: heparan sulphate, dermatan sulphate, and chondroitin sulphate.  Danaparoid, has well established antithrombotic activity. The drug has a high antifactor Xa to antifactor IIa (thrombin) activity ratio, a low tendency to cause bleeding and minimal effects on the fibrinolytic system.

Purity: Min. 95%

Color and Shape: White Powder

Ref: 3D-YD58324

Dermatan Sulfate

CAS: 54328-33-5

Ref: 4Z-D-185001